ArticleJournal of pain research2026
Proportion of Myofascial Pain Syndrome Among Patients with Diagnosed or Suspected Fibromyalgia: A Pilot Cross-Sectional Study.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The present study aimed to investigate the proportion of myofascial pain syndrome (MPS) among patients with definitively diagnosed or suspected fibromyalgia (FM), and to compare patients ultimately diagnosed with MPS and those diagnosed with FM, as well as to describe the clinical characteristics of the MPS group. Patients and Methods: This retrospective cross-sectional study was conducted at a university hospital. Clinical data were retrospectively extracted from electronic medical records of patients referred with suspected or diagnosed FM between January 2018 and December 2022. Available clinical information was limited to routinely documented data in referral documents and medical records. Patients included those definitively diagnosed with FM, as well as those suspected of FM based on established criteria or on the opinion of a rheumatologist or an FM expert. Final diagnoses were reassessed by one of the authors, who reviewed the original documentation to assess reclassification as MPS, based on regional pain, myofascial trigger points, and taut bands of muscle fibers. Results: A total of 29 patients were identified as potentially eligible, and 28 were included in the final analysis (mean age, 48.8 years; 28.6% male). Of the 29 patients, 25 (86.2%) were ultimately diagnosed with MPS. Compared with the FM group, the MPS group was older, responded better to local treatments, and reported less fatigue. A substantial proportion of patients with MPS had upper back pain and chronic widespread pain. Conclusion: In this retrospective record-based study, most patients with diagnosed or suspected FM were ultimately diagnosed with MPS. Although several clinical features distinguished MPS from FM, patients in the MPS group in this referral-based cohort frequently exhibited upper back pain and chronic widespread pain, features typically associated with FM, which may contribute to diagnostic confusion. Careful physical examination and assessment of response to local treatments may improve diagnostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.